2022 Annual Meeting

Session: Advances in Drug Discovery Processes (including HTE): Advanced Technology Approaches to Maximize Public Health Impacts

Chair

Co-Chair

Presentations

03:30 PM

(565a) CDER Efforts on Pharmaceutical Manufacturing Modernization

03:51 PM

(565b) Molecular Discovery with Limited Human Input Using a Machine Learning Guided Automated Platform

04:12 PM

(565c) Computational Discovery of Peptide Inhibitors That Neutralize C. Diff. Toxin a in Jejunum and Colon Epithelial Cells

04:33 PM

(565d) Identification of Resistance Determinants in Laboratory Evolved Mycobacterium Smegmatis evolved Under Temporally Variable Drug Profiles

04:54 PM

(565e) Prediction of the Formation of Co-Amorphous Systems By Means of a Machine Learning Approach

05:15 PM

(565f) Engineered Anti-CD276 Mab to Deliver Payload for Cancer Treatment

05:36 PM

(565g) A New Strategy for Persister Control